RegenaLife
Regenalife is a Canadian-based longevity medtech company offering MedAdvance™, an AI-enabled functional medicine program that provides the earliest detection and intervention for major diseases including cancers, cardiovascular, and neurological disorders. Their business model integrates advanced biomedical scans, whole genome sequencing, and personalized treatment plans combining diagnostics and health optimization therapies. Regenalife differentiates itself by leveraging cutting-edge AI technologies and global partnerships to deliver proactive, preventative healthcare locally, working alongside public healthcare systems. Their comprehensive offerings include MedAdvance Baseline, Cancer, Heart, Brain, and Complete packages, supported by a multidisciplinary clinical team. Regenalife aims to extend healthspan and lifespan through continuous monitoring and innovative, evidence-based interventions, positioning itself as a leader in precision longevity medicine.
RegenaLife
Regenalife is a Canadian-based longevity medtech company offering MedAdvance™, an AI-enabled functional medicine program that provides the earliest detection and intervention for major diseases including cancers, cardiovascular, and neurological disorders. Their business model integrates advanced biomedical scans, whole genome sequencing, and personalized treatment plans combining diagnostics and health optimization therapies. Regenalife differentiates itself by leveraging cutting-edge AI technologies and global partnerships to deliver proactive, preventative healthcare locally, working alongside public healthcare systems. Their comprehensive offerings include MedAdvance Baseline, Cancer, Heart, Brain, and Complete packages, supported by a multidisciplinary clinical team. Regenalife aims to extend healthspan and lifespan through continuous monitoring and innovative, evidence-based interventions, positioning itself as a leader in precision longevity medicine.